12 of 84 items displayed
The rise of automated workers: Part 1 – should we be worried?
Jasmine Patel and Jessica Hunt from the employment team discuss the rise of automated workers
Sarcoma Awareness Month – an opportunity to raise crucial awareness of the 'forgotten cancer'
Frankie Rhodes from the clinical negligence team discusses sarcoma, which is often labelled the 'forgotten cancer'
It should not pay to turn a blind eye
Liana Wood questions how such wide-spread exploitation could be carried out in plain sight following the largest ever modern slavery ring was uncovered in the UK
Disabled prisoners are being failed by the current prison system
Benjamin Burrows and John Crowley, from the prison law team, discuss the recently reported failings of the Prison Service to meet the needs of disabled prisoners
Emerade adrenaline pens defect reported
Michelle Victor and Jennifer Ellis, from the food safety team, discuss the recent reports of defects in Emerade adrenaline pens, a device Jennifer herself relies upon in case of a potentially fatal reaction.
Action Mesothelioma Day: A time to remember, a time to keep up the fight
On Action Mesothelioma Day, Steven Dickens discusses the advances in the treatment of mesothelioma, whilst looking at how far treatment has come and the battles still to be fought
Spinal cord injury conference Guttmann 2019 – Life is full of possibilities
Dan Easton discusses this year's Guttmann conference, an annual educational event for spinal cord injury specialists.
Early diagnosis is key in the rare cancer linked to textured breast implants
Zahra Nanji is currently investigating a legal claim for women who have Allergan textured breast implants linked to a rare form of cancer known as BIA-ALCL
Why words matter, Boris
As Boris Johnson's actions rightfully come under increasing public scrutiny, human rights solicitor Sean Humber discusses the importance of critically examining the language that he uses.
Beating a Part 36 offer, consequences, severability and penalties
Suzanne White and Matthew Westlake discuss their recent successful appeal of the decision by the Senior Courts Costs Office regarding Part 36 offers.
Health Canada suspends licences for Allergan's Biocell breast implants
Zahra Nanji discusses the recent announcement by Health Canada to suspend licences for Allergan's Biocell breast implants, due to concerns about links to a rare form of cancer